Advertisement

Select Brand 44-292 | Ibuprofen

06:21 EDT 21st May 2013 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

 Ibuprofen USP, 200 mg (NSAID)*

*nonsteroidal anti-inflammatory drug

 Pain reliever/fever reducer

 Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

If an allergic reaction occurs, stop use and seek medical help right away.

Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:

 ask a health professional before use. It is especially important not to use ibuprofen during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

 In case of overdose, get medical help or contact a Poison Control Center right away.

 carnauba wax, corn stach, fumed silica gel, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, red iron oxide, sodium starch glycolate, stearic acid, titanium dioxide

 Call1-800-426-9391 8:30 AM-4:00 PM ET, Monday - Friday

select brand®

the lower price name brand

NDC 15127-335-50

SAFETY SEALED

IBUPROFEN

CAPLETS USP, 200 mg

PAIN RELIEVER / FEVER REDUCER (NSAID)

†Compare to the active ingredient of Advil®

50 CAPLETS**

**CAPLETS (Capsule-Shaped Tablets)

TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

50844   REV0411C29215

Distributed by:

SELECT BRAND® DISTRIBUTORS

Pine Bluff, AR 71603 USA AC (870) 535-3635

IMAGE select-brand-44-292-1.jpg

Manufacturer

Stephen L. LaFrance Pharmacy, Inc.

Active Ingredients

Source

Clinical Trials [ 114 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-Associated Ulcers

The purpose of this study is to evaluate whether HZT-501 is effective in reducing the rate of development of ibuprofen-associated ulcers in patients who require long-term daily use of ibup...

Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients

The primary objective of this study is to evaluate the efficacy of intravenous ibuprofen on reducing fever at 4 hours.

Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment

The purpose of this study is to evaluate whether HZT-501 is effective in reducing the rate of development of ibuprofen-associated ulcers in patients who require long-term daily use of ibup...

Study Evaluating a Novel Ibuprofen Formulation in the Treatment of Dental Pain

This study will compare the analgesic efficacy of a single-dose of a novel ibuprofen formulation to placebo and two formulations of standard ibuprofen in the treatment of post-surgical den...

Comparison of the Efficacy of Topical Ibuprofen to Oral Ibuprofen in Adolescent Athletes

This study was made to compare the efficacy of topical ibuprofen in gel form with oral ibuprofen in the treatment of sub-acute soft tissue injuries while comparing the tolerability of the...

PubMed Articles [ 283 Associated PubMed Articles listed on BioPortfolio]

Ibuprofen-phospholipid solid dispersions: Improved dissolution and gastric tolerance.

Solid dispersions of ibuprofen with various phospholipids were prepared, and the effect of phospholipids on the in vitro dissolution and in vivo gastrointestinal toxicity of ibuprofen was evaluated. M...

Development of novel ibuprofen-loaded solid dispersion with enhanced bioavailability using cycloamylose.

To develop a novel ibuprofen-loaded solid dispersion with enhanced bioavailability using cycloamylose, it was prepared using spray-drying techniques with cycloamylose at a weight ratio of 1:1. The eff...

Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.

Summary Background and purpose. Recently, we identified etodolac as a possible ligand for the human intestinal proton-couple peptide transporter (hPEPT1). This raised the possibility that other NSAIDs...

Drug nano-domains in spray-dried ibuprofen-silica microspheres.

Silica microspheres encapsulating ibuprofen in separated domains at the nanometre scale are formed by spray-drying and sol-gel processes. A detailed (1)H and (13)C NMR study of these microspheres show...

pH-sensitive polymer hydrogels derived from morpholine to prevent the crystallization of ibuprofen.

Various pharmaceutical formulations of ibuprofen are available including oral tablets, suspensions, suppositories and transdermal gels and creams. Aqueous ibuprofen solubility is dependent on pH incre...

Search BioPortfolio:
Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record

Advertisement